Irinotecan Hydrochloride

CAS 136572-09-3 8 FDA-DMF suppliersSmall Molecule

Overview

Irinotecan Hydrochloride is a topoisomerase inhibitor used in cancer therapy, particularly for colorectal cancer. It works by interfering with the DNA replication process, thereby inhibiting cell proliferation.

API suppliers (9)

Suppliers of Irinotecan Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • SCINOPHARM TAIWAN LTD1 active DMF
  • SCINOPHARM TAIWAN LTD1 active DMF
  • FERMION OYFinland1 active DMF
  • FERMION OYFinland1 active DMF
  • SCINOPHARM TAIWAN LTD1 active DMF
  • FERMION OYFinland1 active DMF
  • Kisun Pharmaceutical Co., Ltd.China1 active DMF
  • Zhejiang Hisun Pharmaceutical Co., Ltd.China
  • Pharmaron Beijing Co., Ltd.China

Therapeutic areas

OncologyGastrointestinal CancersColorectal Cancer

Related APIs

Paclitaxel
33 suppliers
Anastrozole
28 suppliers
Capecitabine
27 suppliers
Bicalutamide
26 suppliers
Zoledronic Acid
25 suppliers
Dasatinib
24 suppliers
Bortezomib
24 suppliers
Deferasirox
24 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo